Companies: 10,795·Total market cap: $144.5T
iBio, Inc.

iBio, Inc.

IBIONASDAQHealthcare● Active
$1.76
+$0.03(+1.45%)
Market Cap$27710525
P/E Ratio
52W High$3.82
52W Low$0.56

iBio, Inc. (IBIO) Revenue

Annual & quarterly revenue history · segment & region breakdown

IBIO · revenue · updated Jun 10, 2026

Core revenue metrics

iBio, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
92.37×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$19K
16 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · iBio, Inc. SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
IBIO revenue by year · IBIO revenue history · IBIO annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income iBio, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

iBio, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from iBio, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

IBIO revenue · 4 questions

IBIO's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

IBIO revenueIBIO annual revenuewhat is IBIO revenueIBIO TTM revenue

Source: FMP · iBio, Inc. SEC filings · GAAP · iBio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026